Clinical Exacerbation Developing During Treatment of Cutaneous Leishmaniasis: An Id Reaction?

Abstract

Clinical exacerbations were found in the patient being monitored in the dermatology clinic, 3 days after the start of systemic sodium stibogluconate treatment for cutaneous leishmaniasis (CL). The patient was the 5-year-old daughter of the first patient, who also had facial CL lesion, and the clinical exacerbation was seen on the 3rd day of treatment (systemic sodium stibogluconate) (Figure 1). This treatment was continued in both patients with the addition of 0.5 mg/kg prednisolone for 3 days. Rapid clinical recovery was shown in both patients with systemic corticosteroid (Figures 1d and 2d).